Quarterlytics / Healthcare / Biotechnology / Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics, Inc.

ALDX · NASDAQ Healthcare
Claim this profile
Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Employees 9
Overview Coverage Annual Reports FAQ Peers Earnings Calls Financials News Management
Company Profile
Aldeyra Therapeutics: Can a RASP-Based Ocular Strategy Bridge the Gap to Revenue?
When Aldeyra Therapeutics won FDA acceptance for two eye-disease drug applications on the same March 2023 day, management framed the event as validation of a lo…
ALDX Jun 19, 2026